Table 2 AFP and CgA levels of the subjects included in the study according to the BCLC classification
From: Elevated serum levels of Chromogranin A in hepatocellular carcinoma
α-Fetoprotein | CgA | |
|---|---|---|
Controls | 3.8 ± 1.2 | 73 ± 10 |
Stage 0 | 16 ±4 | 96 ± 6 |
Stage A | 24 ± 6 | 102 ± 10 |
Stage B | 36 ± 8 | 125 ± 12 |
Stage C | 74 ± 24 | 145 ± 96 |
Stage D | 128 ± 36 | 210 ± 110 |